NCT06240741 2026-02-03
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Novartis
Phase 3 Completed
Clinical Trials
13 trialsNCT03598426 2025-09-03
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity
Loma Linda University
Phase 3 Completed
NCT01837693 2025-06-26
NTCC2
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT01673906 2025-06-24
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Azienda USL Reggio Emilia - IRCCS
Phase 2 Completed
NCT02349763 2020-10-23
DEPARO
Department of Medical Services Ministry of Public Health of Thailand
Phase 3 Completed
NCT01091545 2019-11-13
MBTST
Region Skane
Phase NA Completed
NCT01663753 2019-01-07
ERRICC
Hospices Civils de Lyon
Phase NA Completed
NCT01206777 2017-12-20
Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT02829021 2016-07-12
Dynamic Infrared Thermography in Breast Cancer Diagnostics
University Hospital of North Norway
Phase NA Completed
NCT01033123 2016-03-17
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Sanofi
Phase 2 Completed
NCT01033292 2016-03-17
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Sanofi
Phase 2 Completed
NCT01658280 2016-02-03
Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
Azienda Ospedaliero, Universitaria Ospedali Riuniti
Phase 4 Completed
NCT00116610 2009-01-21
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Poniard Pharmaceuticals
Phase 2 Completed